RECENT NEWS
Benzinga  Apr 18  Comment 
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at SurModics (NASDAQ: SRDX) is 33.41%. SurModics' ROE for the same period is...
Benzinga  Mar 20  Comment 
Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX) is $1.29 billion. IDEXX had $223.99 million in total cash for the latest quarter. The...
Benzinga  Feb 21  Comment 
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter. Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis'...
Benzinga  Jan 24  Comment 
Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue estimate for the current year. Analysts expect IDEXX Laboratories (NASDAQ: IDXX) to post revenue of $1.30 billion for the year ending December, 2012. IDEXX had...
Benzinga  Jan 8  Comment 
Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's revenue for the same period is $81.70...
Benzinga  Dec 20  Comment 
Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is...
Benzinga  Oct 24  Comment 
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the...
Benzinga  Oct 10  Comment 
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio...
Benzinga  Sep 21  Comment 
Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.32%. Trinity Biotech's ROE for the same period is 10.69%. The...
Benzinga  Aug 2  Comment 
Below are the top diagnostic substances stocks on the NASDAQ in terms of cash. AMAG Pharmaceuticals (NASDAQ: AMAG) had $207.25 million in total cash for the latest quarter. However, AMAG Pharmaceuticals had no debt for the same period. IDEXX...




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki